Learn More
Apexbio Technology LLC PD173955 260415-63-2 5mg

Supplier: Apexbio Technology LLC A88125
PD173955 (CAS 260415-63-2) is a small-molecule inhibitor targeting Bcr-Abl Src and Yes tyrosine kinases with reported IC50 values of 1 2 nM 300 nM and 175 nM respectively Bcr-Abl is associated with oncogenic transformation while Src and Yes are implicated in tumor cell survival proliferation and invasion In cellular assays PD173955 inhibits KL-dependent proliferation of CML CD34 progenitor cells (IC50 50 nM) and reduces G2-M phase cell populations accompanied by an increase in G1 phase cells In HT29 and Bcr-Abl-dependent cell lines PD173955 suppresses proliferation and Src autophosphorylation This compound is widely used in studies investigating kinase signaling and cell cycle regulation in cancer research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.